INTRODUCTION
cancer, prostate cancer, breast, colorectal, and
CANCER, PROSTATE CANCER
With the aging population and advances in early cancer detection and treatment, the number of cancer survivors now exceeds 16 million in the United States.Surveillance patterns are likely influenced by factors at multiple levels, including the health system, patient, and provider levels. From a randomized, controlled trial of SCP delivery at both an urban‐academic and rural‐community cancer center, we previously determined how SCP surveillance recommendations aligned with national guidelines for breast, colorectal, and prostate cancer survivors and found gaps related to follow‐up recommendations.